[Skip to Navigation]
Sign In
Invited Commentary
March 30, 2022

Living-Donor Liver Transplant for Unresectable Colorectal Liver Metastases—Let’s Walk, Not Run

Author Affiliations
  • 1Solid Organ Transplantation, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio
  • 2Division of Surgical Transplantation, Department of Surgery, University of Texas Southwestern Medical Center, Dallas
JAMA Surg. 2022;157(6):530-531. doi:10.1001/jamasurg.2022.0301

There has been growing enthusiasm in the transplantation community for liver transplant for colorectal liver metastases (CRLMs). Hernandez-Alejandro et al1 present a prospective series of 10 living donor liver transplants (LDLTs) for this indication, from 3 high-volume and leading transplant institutions in North America. This represents, to our knowledge, the first series published outside of the Oslo experience,2,3 and the study by Hernandez-Alejandro et al1 focused on the use of living donation as a means for transplant given the shortage of organs from deceased donors in the US and Canada.

Add or change institution